期刊
LEUKEMIA RESEARCH
卷 36, 期 9, 页码 1193-1199出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2012.04.007
关键词
Acute Myeloid Leukemia (AML); Dendritic cell; TLR agonists
资金
- Tehran University of Medical Sciences [8606-30-01-88]
- Hematology, Oncology and Bone Marrow Transplantation Research Center (Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran)
Leukemic cells from AML patients can be differentiated to dendritic cells (DCs). Such DCs have potential for immunotherapy of patients. Blasts from 15 AML patients were differentiated into DCs and matured by different TLR agonists. We could generate AML-DCs from 73% of patients mostly with M4 or M5 subtypes. The DC recoveries ranged from 28% to 50%. The results showed that concomitant use of TLR4 and TLR7/8 agonists induced proficient DCs. Therefore, a combination of TLR4 and 7/8 agonists can be considered as an appropriate maturation cocktail for AML-DC production in order to use in the immunotherapy of AML patients. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据